SRPT Sarepta Therapeutics
$17.31 -1.03%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.03%
YTD
-25.10%
P/E
—
P/B
1.98
ROE
-10%
Div yield
—
Beta
2
Market cap
$1.8B
RSI (14)
37
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$17.60
Close
$17.31
VWAP (n/a)
—
Day high
$17.65
Day low
$17.04
Volume
2.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · Sep 30
Sarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Older Ambulatory Patients with Duchenne
Yahoo Finance · Sep 30
Why Sarepta Therapeutics (SRPT) Is Down 7.2% After AAVrh74 Patent Peace With REGENXBIO And UPenn
Yahoo Finance · Sep 26
Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress
Yahoo Finance · Sep 25
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
Yahoo Finance · Sep 15
Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near
Yahoo Finance · Sep 15
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 23, 2026 View → 8-K Aug 5, 2026 View → 10-Q Aug 5, 2026 View → 8-K Jul 27, 2026 View → 8-K Jun 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell SRPT. Try it in the Lab to size a position and see the risk.